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ABSTRACT:
Acute disseminated encephalomyelitis (ADEM) is an autoimmune condition that predominately involve
demyelination of the white matter of the brain and spinal cord. It resembles other acute demyelinating syndromes like
multiple sclerosis and most often presents in childhood.This is a case of a 52-year woman, presented with lower limb
weakness, confusion and spasticity throughout the body with no preceding illness. CSF showed increased proteins
with no oligoclonal bands. MRI Brain showed abnormal high intensity areas in bilateral parietal, periventricular
region, with no contrast enhancement. She was given 1gram iv methylprednisolone based on the diagnosis of ADEM
and responded well.
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INTRODUCTION:
Acute disseminated encephalomyelitis (ADEM) is a
monophasic autoimmune inﬂammatory demyelinating
disease of brain and spinal cord. Mostly young and
adolescent children are affected and the documented
incidence is 0.8 per 100 000 population per year (1).
The autoimmune response to myelin basic protein that
is T-cell mediated, triggered by an infection or
vaccination, underlies its pathogenesis (2). The
differentiation of ADEM from a ﬁrst attack of multiple
sclerosis is crucial as it has both prognostic and
therapeutic implications. MRI ﬁndings can be a helpful
tool to label ADEM and high dose steroids is the
treatment of choice for ADEM. Other options like
immunosuppressants, plasmapheresis and iv
immunoglobulins are given in refractory cases.

fasciculations. Muscle bulk was normal in all four
limbs, with a power of 3/5, hypertonia and brisk
reﬂexes with no clonus in all four limbs, and the
plantars were bilaterally down going. Cerebellar
examinationcouldn't be done because of stiffness of
limbs. Signs of meningeal irritation were absent. Her
lab workup showed Hb=12.9g/dl, Wbc=12.5x109/l,
Platelets=310x109/l, UCE, Calcium levels, LFTs, TSH
and serum B12 levels were normal. Vasculitis work up
came out to be normal. CSF DR showed;
RBC=50cells/ul, WBC=5cells/ul, sugar=69mg/dl,
(BSR=110mg/dl) and protein-50mg/dl. CSF was
negative for oligoclonal bands. EEG and VEP were
normal.MRI brain was done that showed abnormal
high intensity areas seen in bilateral parietal,
periventricular region, these show high signals on ADC
image. On subsequent post contrast T1 weighted
images, no signiﬁcant enhancement is noted in such
areas, ﬁndings are suggestive of ACUTE
DISSEMINATED ENCEPHALOMYELITIS. (ﬁg a-c)

CASE REPORT:
This is a case report of a 52 years old diabetic female
presented with complaints oﬁnability to walk
secondary to progressive lower limb weakness and
dysphagia for 1 month and generalized body stiffness
for 1 week.She was unable to walk for 1 monthneither
she could perform her daily chores. There was no
history of paresthesia or pain in legs, no history
ofpreceding viral illness or vaccination. On
examination; she was vitally stable,but confused. Her
pupils were bilateral equally reactive to light,
extraocular movements were normal, uvula centrally
placed but gag reﬂex was poor.All sensory modalities
of both upper and lower limbs were intact, with no
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medicines[4].There-fore it can also be named as postinfectious encephalomyelitis and immune-mediated
encephalomyelitis. Acute disseminated
encephalomyelitis has an annual reported incidence
of0.4–0.8 per 100,000 [5,6]. Children and young adults
are commonly affected in winter and spring
season[5,6]. There is no gender predominance and the
mean age at the onset of symptoms is 6-8 years [7, 8].
The survival rate with minor residual disability is 70 to
90%, while complete recovery is seen in 50 to 75%
cases, with the mortality rate of 5% [6].
ADEM is a monophasic disease. It manifests clinically
as sudden onset multifocal neurologic deﬁcit including
seizure disorder, motor, sensory and visual ﬁeld
defects, aphasia, movement disorders, impaired
sensorium,and psychosis [9]. Our patient presented
with both lower limbs weakness, dysphagia, rigidity
and confusion. But the diagnostic dilemma in our case
is that there is no clinical evidence of any previous
illness or immunization, as the acute phase of ADEM
presents about 4–21 days after the preceding infection
[9].The diagnosis is made on the basis of exclusion, as
it is difﬁcult to differentiate clinically between ADEM
and viral encephalomyelitis. MRI is a very useful tool in
diagnosing ADEM. The MRI, T2 images shows
widespread lesions consistent with inﬂammation,
demyelination and edema in the white matter, basal
ganglia, thalamus, and brainstem [7].CSF protein can
be mildly elevated, sometimes with lymphocytic
predominance. The presence of oligoclonal
immunological bands, IgG or myelin basic protein
(MBP) does not add to the diagnosis of ADEM [10].
There are non-speciﬁcfeatures on EEG, and VEP
shows delayed responses. Our patient's brain MRI
ﬁndings are very suggestive of ADEM, while the CSF
studies are normal, and oligoclonal bands not detected
along with normal VEP results are adding to the
diagnosis of ADEM rather than MS.
The treatment of choice is high doses of intravenous
corticosteroids [11] like methylprednisolone
(20–30 mg/kg/day) for 3–5 days followed by oral
prednisolone tapered over 4–6 weeks. There are high
chances of relapse if steroids are tapered before three
weeks[12, 13]. The second line treatment is
intravenous immunoglobulin, if high-dose
corticosteroids use is contraindicated or the disease is
refractory to steroids. However, plasmapheresis is
recommended in severe cases [11, 14].The
immunosuppressive drugs like cyclophosphamide and
mitoxantrone are the alternate treatment options in
refractory cases [6]. Decompressive craniotomy is
done in cases of intracranial hypertension [15]. Our
patient responded well to high dose steroid therapy
and clinically improved.

Mri Showing High Intensity Areas In
B/l Parietal, Periventricular Regions
During hospital stay initial suspicion was Parkinson's
disease due to increased rigidity and mask like face.
Initially patient was given supportive treatment,
physiotherapy and anti-Parkinson drugs. As MRI
BRAIN revealed thediagnosis of Acute Disseminated
Encephalomyelitis (ADEM), the patient was started on
intravenous methylprednisolone 1gram per
day.Patient was improved on third day of intravenous
steroids and her rigidity improved and she started
responding to commands. She was discharged on oral
steroids and was called for follow-up.Her symptoms
did not recur over a follow up duration for 6 months.
Keeping this in view, the diagnosis of ADEM is much
strengthen as compared to other diseases mimicking
ADEM on radiological basis like Adult onset
leukodystrophies, CNS lymphoma and PML.
DISCUSSION:
Acute disseminated encephalomyelitis (ADEM) is an
autoimmune disease that predominantly involve the
white matter of brain and spinal cord [3].The triggering
factors are bacterial, viral or parasitic infections, after
immunization or after taking some
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